UL

ePharmaSolutions to acquire global patient recruitment firm Polaris BioPharma

Wednesday, June 20, 2012 03:06 PM

ePharmaSolutions, a clinical services and technology solutions provider, has acquired Polaris BioPharma Consulting, a global patient recruitment and retention firm based in Slough, U.K., to meet client demand for more "in-country" site feasibility and patient recruitment support on global clinical studies.

More... »

Modulation Therapeutics receives $500,000 from MMRF for cancer treatment

Monday, June 11, 2012 11:54 AM

The Multiple Myeloma Research Foundation (MMRF) has awarded $500,000 through its Biotech Investment Award (BIA) program to Modulation Therapeutics, an early-stage pharmaceutical company which has licensed MTI-101 from the Moffitt Cancer Center.

More... »

AMR offers new “core team” service

Friday, June 1, 2012 02:56 PM

The Alliance for Multispecialty Research (AMR), based in Spring Hill, Tenn., is offering a new gratis service developed by its Alliance of 16 independently owned and managed clinical research centers of excellence across the U.S. and implemented on several recent sponsors' programs, including bioterrorism vaccines, obesity, and tobacco-related projects. 

More... »

CMO revenue could double in Europe, says Frost & Sullivan

Thursday, May 31, 2012 03:10 PM

New analysis from Frost & Sullivan, "European Pharmaceutical and Biotech Contract Manufacturing Markets," finds that the European pharmaceutical contract manufacturing market earned revenues of $10.02 billion in 2011 and estimates this to reach $20.75 billion in 2018. Over the same period, the European biotech contract manufacturing market is set to expand from $1.21 billion to an estimated $2.67 billion.

More... »

Takeda to acquire Multilab in Brazil

Wednesday, May 30, 2012 10:31 AM

Takeda Farmacêutica Brasil, a wholly-owned subsidiary of Takeda Pharmaceutical, has agreed to acquire Multilab Industria e Comercio de Produtos Farmaceuticos of Sao Paulo, Brazil.

More... »

Regulus Therapeutics appoints Bruce Carter to board of directors

Wednesday, May 2, 2012 04:38 PM

Regulus Therapeutics, a biopharmaceutical company focused on medicines targeting microRNAs, has appointed Bruce Carter, Ph.D., to its board of directors.

More... »

AMRI hires director of in vitro biology in Singapore

Monday, April 30, 2012 04:41 PM

AMRI, a global CRO, has added Saravanakumar Dhakshinamoorthy, Ph.D., to the ranks of its management team in Singapore, serving as director of in vitro biology.

More... »

MDI completes $1.9M Series B financing for Detect-Ready tests

Tuesday, April 17, 2012 07:30 AM

Molecular Detection Inc. (MDI), a Berwyn, Penn.-based company developing Detect-Ready tests designed to increase the speed and accuracy of infectious disease diagnosis, has completed a $1.9 million Series B recapitalization financing. 

More... »

Analysis: U.S. CMO market reviving, offering preclinical services

Tuesday, April 10, 2012 11:27 AM

The upturn in the fortunes of pharmaceutical companies after the recession is mirrored by the U.S. contract manufacturing outsourcing (CMO) market, which is expected to grow at a compound annual growth rate of 8.3% from 2011 to 2016, according to Frost & Sullivan's newest analysis of the U.S. CMO market.

More... »

UL acquires EduNeering

Tuesday, April 10, 2012 06:30 AM

Global safety science company UL has acquired EduNeering, a provider of compliance and training solutions for the life and health sciences sector, from educational and career service Kaplan.

More... »